activistletters
Biglari Capital Targets Board Accountability at Jack in the Box (JACK), Citing Governance Failures and Value Destruction
Summary
Biglari Capital calls on Jack in the Box shareholders to vote AGAINST Chairman David Goebel, blaming an entrenched board
activistletters
Endeavor Investor Group Calls for Leadership Change and Strategic Reset at Mawson Infrastructure Group (MIGI)
Summary
Endeavor Investor Group, a significant shareholder, argues Mawson’s HPC and digital infrastructure assets are materially undervalued due to
activistletters
Star Equity Holdings (STRR) Sends Proposal to GEE Group (JOB), Highlighting Valuation Upside and Strategic Alternatives
Summary:
Star Equity Holdings sent a non-binding, confidential letter to GEE Group on January 6, 2026 proposing a potential merger,
activistletters
Tredegar Corporation (NYSE: TG) Pressured by John D. Gottwald to Sell Bonnell and Surface Protection Films, Exit Public Markets
Summary
On January 14, 2026, John D. Gottwald issued an open letter to Tredegar’s board arguing that, despite confidence
activistletters
Galloway Capital Presses Chicago Rivet (CVR) on Market Mispricing, Calls for Enhanced Investor Outreach
Summary
Galloway Capital Partners, which owns about 6.45% of Chicago Rivet & Machine Co., argues that the company is
activistletters
Ampco Pittsburgh (AP) Draws Activist Support From Galloway Capital Partners as Letter Highlights Valuation Gap and M&A Options
Summary
Galloway Capital Partners disclosed that it has built a 5.19% stake in Ampco Pittsburgh over the past 18
activistletters
STAAR Surgical (STAA) Faces Intensifying Pushback as Broadwood Partners Opposes Sale and Presses for Independence
Summary
Broadwood strongly opposed STAAR Surgical’s proposed sale to Alcon, arguing the deal materially undervalues the company and reflects
activistletters
OraSure Technologies (OSUR) Faces Proxy Fight as Altai Capital Seeks Board Seats Over Governance and Strategic Failures
Summary
Altai Capital disclosed a 5.2% stake in OraSure and sharply criticized the Board for clinging to a failed
activistletters
Global Crossing Airlines (JET) Draws Activist Interest as Galloway Capital Pushes M&A or Going-Private Options
Summary
Galloway Capital disclosed that it has increased its stake in Global Crossing Airlines to 6.24%, reiterated its view
activistletters
Yunqi Capital Challenges STAAR Surgical (STAA) Board, Rejects Alcon Merger Over Timing, Process, and Valuation
Summary
In a December 10, 2025 letter, Yunqi Capital reiterated its opposition to STAAR Surgical’s proposed sale to Alcon,
activistletters
Broadwood Partners Targets STAAR Surgical (STAA) Over Flawed Sale Process and Undervalued Alcon Offer
Summary
Broadwood Partners’ supplemental presentation argues that Alcon’s proposed acquisition of STAAR Surgical should be rejected because it is
activistletters
Lifeway Foods (LWAY): Smolyansky Shareholders Push Director Replacements and Challenge Governance Amid Danone Fallout
Summary
The presentation argues that Lifeway’s largest shareholders, Edward and Ludmila Smolyansky (26% owners), are pushing for board change
activistletters
Scully Royalty (SRL): Activist Shareholder MILFAM LLC Accuses Board of Blocking Valid Director Nominees and Manipulating AGM Process
Summary
MILFAM LLC, a 13% shareholder of Scully Royalty, rejects the company’s claim that its director nominations were invalid,
activistletters
Alaunos Therapeutics (TCRT): Activist Shareholder Group Seeks Board Seat for Gerald W. Bruce Amid Strategic Concerns
Summary
The shareholder group holding 8.61% of Alaunos Therapeutics urges the board to accept their formal nomination of Gerald
activistletters
BILL Holdings (BILL): Activist Barington Capital Urges Board to Review Strategy and Reduce Costs as Growth and Monetization Slow
Summary
Barington Capital, a BILL shareholder, argues that despite the company’s strong positioning in B2B financial automation and solid
activistletters
First Industrial (FR): Land & Buildings Presses Board on Mispriced Portfolio, Urges Steps to Unlock 30% NAV Upside
Summary
Land & Buildings argues that First Industrial (FR) is a high-quality industrial warehouse REIT trading at an unjustified discount
activistletters
Neuphoria Therapeutics (NEUP): Lynx1 Challenges Board’s Strategic Review and Capital Decisions, Refiles Offer and Nominates Two Independent Directors
Summary
Lynx1, the largest shareholder of Neuphoria, argues that the company’s severe value destruction—driven by failed trial design,
activistletters
Noodles & Company (NASDAQ: NDLS) Urged by Galloway Capital to Pursue Asset Sales and Deleveraging Strategy
Summary
The letter argues that Noodles & Company is undervalued and urges the Board to sell roughly 200 company-owned restaurants